EVEROLIMUS TABLETS

17092 reported adverse events

Drug classes: Kinase Inhibitor [EPC] mTOR Inhibitor Immunosuppressant [EPC]

These side effects are most commonly reported by patients taking EVEROLIMUS TABLETS:

# Side effect Count
0 MALIGNANT NEOPLASM PROGRESSION 1592
1 OFF LABEL USE 1375
2 DIARRHOEA 1255
3 DRUG INEFFECTIVE 1021
4 FATIGUE 863
5 NAUSEA 782
6 DEATH 766
7 DISEASE PROGRESSION 758
8 PRODUCT USE IN UNAPPROVED INDICATION 755
9 DYSPNOEA 664
See all common reactions for EVEROLIMUS TABLETS

EVEROLIMUS TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VOCAL FOLD IMMOBILITY 13 0.6842
1 GRANULOMATOUS ROSACEA 14 0.2857
2 BIPHASIC MESOTHELIOMA 11 0.2558
3 ADENOVIRUS INTERSTITIAL NEPHRITIS 14 0.2500
4 ACANTHOMA 10 0.1923
5 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 42 0.1772
6 POLYOMAVIRUS VIRAEMIA 182 0.1714
7 PIK3CA-ACTIVATED MUTATION 56 0.1687
8 ISOSPORIASIS 12 0.1538
9 POLYOMAVIRUS TEST POSITIVE 18 0.1525
See all enriched reactions for EVEROLIMUS TABLETS